The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Aiding data retrieval in clinical trials with large language models: The APOLLO 11 Consortium in advanced lung cancer patients.
 
Federica Corso
No Relationships to Disclose
 
Laura Mazzeo
Honoraria - MSD; Novartis
Travel, Accommodations, Expenses - Daiichi Sankyo Europe GmbH; LEO Pharma
 
Vittoria Peppoloni
No Relationships to Disclose
 
Giuseppe Leone
No Relationships to Disclose
 
Vanja Miskovic
Honoraria - Novartis
 
Isabella Wiest
Honoraria - AstraZeneca
 
Cecilia Silvestri
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Mario Occhipinti
Honoraria - AstraZeneca
Consulting or Advisory Role - Pfizer
Travel, Accommodations, Expenses - Lilly
 
Marta Brambilla
Travel, Accommodations, Expenses - Lilly
 
Teresa Beninato
Honoraria - MSD
Travel, Accommodations, Expenses - Lilly; MSD; Pfizer; Sanofi
 
Alberto Ferrarin
No Relationships to Disclose
 
Marco Meazza Prina
No Relationships to Disclose
 
Claudia Proto
Honoraria - AstraZeneca; BMSi; MSD; Roche
Consulting or Advisory Role - AstraZeneca; Janssen; MSD; Roche; Sanofi
Research Funding - AstraZeneca (Inst); BMSi (Inst); Daiichi Sankyo (Inst); Janssen (Inst); Lilly (Inst); MSD (Inst); Pfizer (Inst); Roche (Inst); Spectrum Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Janssen; MSD; Roche
 
Paolo Baili
No Relationships to Disclose
 
Monica Ganzinelli
No Relationships to Disclose
 
Filippo De Braud
Honoraria - BMS; Incyte; Indena; IQVIA; Mattioli 1885; MCCann Health; Menarini; MSD; Pierre Fabre; Taiho Oncology
Consulting or Advisory Role - Bristol-Myers Squibb; Incyte; Pierre Fabre; Sanofi; Taiho Oncology
Speakers' Bureau - Ambrosetti; BMS; Dephaforum; Nadirex International; Novartis
Research Funding - AnHeart Therapeutics; Apollomics; AstraZeneca; BMS
Travel, Accommodations, Expenses - Sanofi
 
Giuseppe Lo Russo
Consulting or Advisory Role - Amgen (Inst); AstraZeneca/MedImmune; Bristol-Myers Squibb/Medarex; Daiichi Sankyo/Astra Zeneca; GlaxoSmithKline; Jhonson and Jhonson; Lilly; Merck Serono; MSD; Novartis; Pfizer; Pierre Fabre; REGENERON; Roche; Sanofi; Takeda
Research Funding - Amgen (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb/Medarex (Inst); Celgene (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); MSD Oncology; MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; BMS; MSD; Roche
 
Jakob Kather
Leadership - StratifAI GmbH; Synagen GmbH
Stock and Other Ownership Interests - StratifAI GmbH; Synagen GmbH
Honoraria - AstraZeneca; Bayer; BMS GmbH & Co. KG; Daiichi Sankyo Europe GmbH; Daiichi Sankyo Europe GmbH; DoMore Diagnostics; Eisai; Fresenius; Janssen; Janssen; MSD; MSD; MultiplexDx; Owkin; Panakeia; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; MultiplexDx; Owkin; Panakeia
Research Funding - GlaxoSmithKline (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Panakeia
 
Alessandra Pedrocchi
Speakers' Bureau - Novartis
 
Arsela Prelaj
Honoraria - AstraZeneca; BMS; BMS; Janssen
Research Funding - AstraZeneca (Inst); Bayer (Inst); BMS (Inst); Lilly (Inst); MSD (Inst)
Travel, Accommodations, Expenses - Janssen